Bayer OA Knee Pain Pilot

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial is testing a procedure called GAE — geniculate artery embolization — for knee osteoarthritis pain, and one of its main goals is tracking adverse events from that procedure. Since it's already active and not enrolling new patients, could you walk me through what the known safety signals for GAE look like so far, and whether it would be appropriate for my situation?
2. 2The trial is measuring whether patients get at least a 50% reduction in pain scores — which is a pretty high bar. Based on what you know about GAE and my current pain levels, is that kind of improvement realistic for someone with my degree of osteoarthritis?
3. 3The study is using specialized MRI scans with contrast dye, called CE-MRI, to track changes in blood flow and joint inflammation in the knee. Does that imaging approach tell us anything meaningful about how well GAE might work compared to what we can already see on my existing scans?
4. 4Since this trial is no longer enrolling, GAE itself is still being studied and isn't a standard treatment — so what are my current standard-of-care options for knee osteoarthritis pain, and how do they compare in terms of evidence and safety to what this trial is exploring?
5. 5The trial tracks synovitis — inflammation of the joint lining — as one of its key measurements. Given that synovitis is part of what this procedure targets, is there any way to tell from my current imaging or symptoms whether synovitis is a significant driver of my knee pain, and would that affect which treatment path makes the most sense for me?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.